FindTrial
Sign In

Establishment of competing nomograms to predict benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer

Establishment of competing nomograms to predict benefit of adjuvant chemotherapy in elderly patients with stage III colon cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060192
Enrollment
Unknown
Registered
2022-05-21
Start date
2022-05-10
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

chemotherapy group:N/A
non-chemotherapy group:N/A

Sponsors

The Affiliated Zhongshan Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 100 Years

Inclusion criteria

Inclusion criteria: Data on elderly patients with stage II colon cancer from 2004 to 2018 (primary only).

Exclusion criteria

Exclusion criteria: 1. Clinicopathological information is incomplete; 2. More than one primary tumor; 3. Unknown cause of death; 4. Histological type ICD-O-3, not 8140/3, 8480/3, 8481/3 or 8490/3; 5. No surgery or only local tumor resection; 6. Survival time is less than a month.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
colon cancer cause-specific survival;—

Countries

China

Contacts

Public ContactLyu Zhihao

The Affiliated Zhongshan Hospital of Guangzhou University of Traditional Chinese Medicine

smulzh@126.com+86 15521012121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026